gracecast- dr. sandip patel- emerging molecular targets in nsclc- egfr exon 20
Published 3 years ago • 63 plays • Length 6:44Download video MP4
Download video MP3
Similar videos
-
6:31
podcast-gracecast- dr. sandip patel- emerging molecular targets in nsclc- kras
-
3:41
testing methods to discover egfr exon-20 disease - lung cancer video library
-
4:41
egfr exon-20 mutation - lung cancer video library
-
6:17
asco 2021 lung recap: amivantamab and mobocertinib for egfr exon 20
-
6:07
amivantamab and mobocertinib for egfr exon-20 disease - lung cancer video library
-
9:15
sunvozertinib & egfr exon 20 insertion nsclc-leading developments & current questions in lung cancer
-
2:41
lung cancer video library - evolving standards for molecular testing in advanced nsclc
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
6:56
gracecast - leading treatment options for patients with negative tumor pd-l1 nsclc with dr. stephen
-
35:02
gracecast-039_lung-cancer_pennell nsclc molecular markers webinar
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
10:19
gracecast- asco lung 2020- new potential treatments for met and ret positive nsclc capmatinib-tabrec
-
10:43
gracecast-007_lung-cancer_optimal treatment of unresectable locally advanced nsclc
-
24:30
gracecast-100_lung-cancer_mm in lc pt 5: dr. spigel on incorporating targets into clinical trials
-
9:49
gracecast - treatment options for patients with nsclc and high tumor pd-l1 expression
-
9:19
gracecast-004_lung-cancer_antiangiogenesis in first line nsclc
-
22:20
gracecast-018_lung-cancer_suresh ramalingam on advanced nsclc